v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Sep. 30, 2025
Current assets    
Cash and cash equivalents $ 189,654 $ 279,783
Short-term marketable securities 136,143 61,137
Accounts receivable, net of allowance for expected credit losses ($3,842 and $4,649, respectively) 143,675 142,181
Inventories 79,082 74,956
Short-term restricted cash 2,414 2,359
Refundable income taxes 5,846 9,728
Prepaid expenses and other current assets 53,150 64,660
Current assets held for sale 71,387 73,535
Total current assets 681,351 708,339
Property, plant and equipment, net 172,427 153,954
Long-term marketable securities 196,087 201,585
Long-term deferred tax assets 494 726
Operating lease right-of-use assets 61,421 54,048
Goodwill 547,457 702,395
Intangible assets, net 85,688 101,814
Long-term income taxes receivable 45,600 45,600
Other assets 8,997 6,115
Noncurrent assets held for sale 76,689 85,006
Total assets 1,876,211 2,059,582
Current liabilities    
Accounts payable 39,381 37,722
Deferred revenue 36,041 31,569
Derivative liability 28,435 33,420
Accrued warranty and retrofit costs 4,047 4,713
Accrued compensation and benefits 30,965 35,799
Customer deposits 35,355 26,499
Accrued income taxes payable 6,775 9,416
Deposit received for the sale of B Medical Systems business 28,000 0
Accrued expenses and other current liabilities 34,249 30,268
Current liabilities held for sale 29,326 28,268
Total current liabilities 272,574 237,674
Long-term deferred tax liabilities 15,836 18,245
Long-term operating lease liabilities 53,967 51,244
Other long-term liabilities 10,725 11,142
Noncurrent liabilities held for sale 12,980 14,291
Total liabilities 366,082 332,596
Stockholders' equity    
Preferred stock, $0.01 par value - 1,000,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.01 par value - 125,000,000 shares authorized, 57,226,616 shares issued and 43,764,747 shares outstanding at June 30, 2026; 59,320,848 shares issued and 45,858,979 shares outstanding at September 30, 2025 572 594
Additional paid-in capital 493,071 529,605
Accumulated other comprehensive loss (28,740) (22,213)
Treasury stock, at cost - 13,461,869 shares at June 30, 2026 and September 30, 2025 (200,956) (200,956)
Retained earnings 1,246,182 1,419,956
Total stockholders' equity 1,510,129 1,726,986
Total liabilities and stockholders' equity $ 1,876,211 $ 2,059,582